new oral glp 1 agonist NEW: This GLP-1 could be a game-changer for people with type 2 diabetes. Swipe to learn more about orforglipron and visit the link in our bio for the full story FDA just approved orforglipron (Foundayo),

We've identified an important new biomarker of major depression disorder

doi: 10.2337/db21-0848 Summary Keywords GLP-1 - glucagon-like peptide-1, GIP - glucose-dependent insulinotropic peptide, obesity, incretin, pharmacology Citation Douros JD, Flak JN and Knerr PJ (2025) The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

Statements Author contributions MM wrote the article

Bildmontage: SVT.Mer om programmet Efter stlden p Louvren har konst- och juvelkupper blivit ett hett samtalsmne

It suppresses the immune system

[DOI] [PubMed] [Google Scholar] 47.Kruithof P.D., Lunev S., Aguilar Lozano S.P., et al